Matches in Wikidata for { <http://www.wikidata.org/entity/Q38974983> ?p ?o ?g. }
- Q38974983 P2860 Q38974983-D26D05C9-9700-4D0C-A5C4-76C158328CF1 @default.
- Q38974983 P2860 Q38974983-D2A486B2-D326-45B6-B87C-49BE1E2406D3 @default.
- Q38974983 P2860 Q38974983-DA2D533B-3379-45AD-8421-8B147A7041B9 @default.
- Q38974983 P2860 Q38974983-DF94AE49-7D8E-4868-86E0-76C71B818AE0 @default.
- Q38974983 P2860 Q38974983-EE1EF516-AAAC-486C-9B20-85B6351795B3 @default.
- Q38974983 P2860 Q38974983-EE60C8BB-6F16-41A2-83F3-D094466A3CF5 @default.
- Q38974983 P2860 Q38974983-F4D4C58C-CFDB-4ADE-BC64-B67F441316F0 @default.
- Q38974983 P2860 Q38974983-F6C97C32-9BC7-4168-817C-6550B021ECC5 @default.
- Q38974983 P2860 Q38974983-F8C9461D-0F0C-4438-A138-463A82A75A83 @default.
- Q38974983 P2860 Q38974983-F9B0E167-3F4E-4630-B03B-E587DAE234AC @default.
- Q38974983 P2860 Q38974983-FBB2DD74-655C-4C5A-9ABB-406D6E330CA0 @default.
- Q38974983 P2860 Q38974983-FF60CDD0-E267-42B4-BB56-69B648606938 @default.
- Q38974983 P304 Q38974983-0765E60E-69B3-4D27-AFFB-D4CBF9364E6B @default.
- Q38974983 P31 Q38974983-567C1382-A3EA-4995-9215-8C79CFF9317F @default.
- Q38974983 P356 Q38974983-F5288368-A298-4583-A2E1-5769FD46E144 @default.
- Q38974983 P433 Q38974983-8A673F32-75A6-415B-B739-4F77CB2A8424 @default.
- Q38974983 P478 Q38974983-52EFED80-346B-4DD9-924B-9038EBC75AC4 @default.
- Q38974983 P50 Q38974983-72F9AF98-F1C7-47D6-8798-57BD679BD9A5 @default.
- Q38974983 P50 Q38974983-CD4CE34B-932E-4D22-81A3-F3F5B3DADA40 @default.
- Q38974983 P50 Q38974983-EBF91C4B-C627-40BC-9966-D6D5E117E06A @default.
- Q38974983 P577 Q38974983-60A96DEA-B725-4E08-80A3-F7B7E71B2FAA @default.
- Q38974983 P698 Q38974983-968FBECF-58EB-4AEC-8AA9-210EC28CDB66 @default.
- Q38974983 P921 Q38974983-7FC756FF-E138-43DE-B0AA-FC356B535A66 @default.
- Q38974983 P356 0960327114542965 @default.
- Q38974983 P698 25028262 @default.
- Q38974983 P1433 Q1636500 @default.
- Q38974983 P1476 "EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells" @default.
- Q38974983 P2093 "E Alp" @default.
- Q38974983 P2093 "E Konac" @default.
- Q38974983 P2093 "E S Menevse" @default.
- Q38974983 P2093 "H I Onen" @default.
- Q38974983 P2093 "I C Kurul" @default.
- Q38974983 P2860 Q28140704 @default.
- Q38974983 P2860 Q28189252 @default.
- Q38974983 P2860 Q28257125 @default.
- Q38974983 P2860 Q28303097 @default.
- Q38974983 P2860 Q29400573 @default.
- Q38974983 P2860 Q34659099 @default.
- Q38974983 P2860 Q34791118 @default.
- Q38974983 P2860 Q34936837 @default.
- Q38974983 P2860 Q35878519 @default.
- Q38974983 P2860 Q36175652 @default.
- Q38974983 P2860 Q36639812 @default.
- Q38974983 P2860 Q36741548 @default.
- Q38974983 P2860 Q36949142 @default.
- Q38974983 P2860 Q37089549 @default.
- Q38974983 P2860 Q37259632 @default.
- Q38974983 P2860 Q37470968 @default.
- Q38974983 P2860 Q38094782 @default.
- Q38974983 P2860 Q39083283 @default.
- Q38974983 P2860 Q39385991 @default.
- Q38974983 P2860 Q39396713 @default.
- Q38974983 P2860 Q39397208 @default.
- Q38974983 P2860 Q39635103 @default.
- Q38974983 P2860 Q39669843 @default.
- Q38974983 P2860 Q39683412 @default.
- Q38974983 P2860 Q39784048 @default.
- Q38974983 P2860 Q39846753 @default.
- Q38974983 P2860 Q39977210 @default.
- Q38974983 P2860 Q40002508 @default.
- Q38974983 P2860 Q40098604 @default.
- Q38974983 P2860 Q40106656 @default.
- Q38974983 P2860 Q40542889 @default.
- Q38974983 P2860 Q42745414 @default.
- Q38974983 P2860 Q42748171 @default.
- Q38974983 P2860 Q43196142 @default.
- Q38974983 P2860 Q46410011 @default.
- Q38974983 P304 "117-126" @default.
- Q38974983 P31 Q13442814 @default.
- Q38974983 P356 "10.1177/0960327114542965" @default.
- Q38974983 P433 "2" @default.
- Q38974983 P478 "34" @default.
- Q38974983 P50 Q54503433 @default.
- Q38974983 P50 Q57020702 @default.
- Q38974983 P50 Q80757011 @default.
- Q38974983 P577 "2014-07-15T00:00:00Z" @default.
- Q38974983 P698 "25028262" @default.
- Q38974983 P921 Q18557602 @default.